Drug discovery companies frequently use high-throughput cell imaging systems to increase the efficiency of secondary screening of drug candidates, and the number of available systems has grown in recent months to meet this demand. Among the competitors is San Diego-based Q3DM's EIDAQ 100 system, the product of a combination of patented technologies that, according to the company, improve throughput and image fidelity over conventional automated cell-imaging systems.
The EIDAQ 100 can collect up to 10,000 images per hour, placing it within the top three automated cell imaging systems in terms of speed, says Mike Honeysett, vice president, sales and marketing. "There are a lot of good systems out there that are very fast, but fidelity of the images, coupled with the analytical software tools, is where we truly shine." That, Honeysett says, is because the EIDAQ 100 employs a patented autofocusing technology that enables the reliable and routine use of ...
